Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Venmax Drugs & Pharmaceuticals Ltd

NSE: VENMAX · BSE: 531015 · Pharmaceuticals & Biotechnology · 17 announcements

Share price
₹14.89
Market cap
₹13.08 Cr
Revenue (annual)
₹8.02 Cr
Net profit (annual)
₹0.25 Cr
P/E (TTM)
46.7×Sector 47.3×
Promoter holding
10.46%-3.34% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

22:13 IST BSE
Acquisition

Venmax Drugs & Pharmaceuticals Acquisition

Venmax Drugs and Pharmaceuticals Limited announced an NCLT-convened meeting of equity shareholders on October 24, 2026, to consider the proposed merger with Hatri Pharma Private Limited.

14:13 IST BSE
Acquisition

Venmax Drugs & Pharmaceuticals Acquisition

NCLT Hyderabad directed Venmax to convene a shareholder meeting on 24 Oct 2026 for the amalgamation of Hatri Pharma into Venmax. The order also dispensed with meetings of Hatri Pharma's shareholders and creditors.